TEOSYAL® PURESENSE KISS

Product Overview: TEOSYAL® PURESENSE KISS

TEOSYAL® PURESENSE KISS is an injectable, non-pyrogenic, transparent viscoelastic gel composed of cross-linked hyaluronic acid (HA) of non-animal origin, containing 0.3% lidocaine hydrochloride for enhanced patient comfort. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this formulation is specifically engineered with rheological properties optimized for the unique requirements of lip tissue, aiming to provide natural-looking volume, definition, and hydration.

It is indicated for lip augmentation (volume enhancement), lip contouring (definition of the vermilion border), rehydration of the lips, and correction of moderate perioral wrinkles.

Note: This medical device is intended for administration solely by licensed medical professionals trained and experienced in lip anatomy and dermal filler injection techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE KISS delivers its effects through the properties of its cross-linked hyaluronic acid gel. Upon injection into the lip mucosa or appropriate dermal plane for perioral lines, it provides immediate volume augmentation. Its specific cohesivity and elasticity are designed to integrate smoothly within the soft, mobile lip tissue, providing natural feel and appearance. The HA component attracts and retains water, contributing significantly to lip hydration and plumpness. The integrated 0.3% lidocaine hydrochloride acts as a local anesthetic, minimizing discomfort during the injection process.

The cross-linking ensures the gel’s persistence, with clinical effects typically lasting several months (often cited around 6-12 months), although duration varies based on individual factors like metabolism, lifestyle, volume injected, and practitioner technique.

Indications and Usage

TEOSYAL® PURESENSE KISS is specifically indicated for aesthetic enhancement of the lips and surrounding area, including:

• Lip volume augmentation
• Enhancement and definition of the vermilion border
• Improvement of lip hydration and texture
• Correction of moderate perioral wrinkles (e.g., vertical lip lines)
• Cupid’s bow enhancement

Injection should be performed into the lip mucosa for volume/hydration or into the appropriate dermal layer for contouring/perioral lines by qualified practitioners using suitable techniques and respecting lip anatomy.

Expected Outcomes

Professional application aims to achieve:

• Natural-looking enhancement of lip volume and shape
• Improved definition and contour of the lips
• Enhanced lip hydration, softness, and texture
• Reduction of moderate lines around the mouth
• High patient satisfaction due to tailored properties and included anesthetic

Potential Adverse Events

Given the vascularity and sensitivity of the lip area, practitioners must thoroughly discuss potential side effects. Common, generally temporary reactions include:

• Common Reactions: Swelling (can be significant in the lips), bruising, redness (erythema), pain or tenderness at injection sites, temporary palpable firmness or lumps. These typically resolve within a few days to a week.
• Less Common/Rare but Serious Reactions: Prolonged swelling or firmness, significant hematoma, infection, hypersensitivity/allergic reaction (to HA or lidocaine), nodule or granuloma formation, skin discoloration, vascular occlusion (a rare but serious complication requiring immediate intervention), tissue necrosis (rare), reactivation of cold sores (herpes simplex).

Careful technique and knowledge of lip anatomy are crucial. Patients should report any severe, prolonged, or unexpected reactions immediately.

Storage Conditions

Store between 2°C and 25°C. Protect from freezing and direct sunlight. Do not use if package is damaged.

Disclaimer: This information serves as a general guide. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE KISS before administration. These instructions contain essential details on indications, contraindications, warnings, precautions, injection techniques, and management of potential adverse events.